Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide-Based Regimens.
Open forum infectious diseases(2023)
摘要
ClinicalTrials.gov NCT03446573.
更多查看译文
关键词
2-drug regimen, cardiometabolic health, insulin resistance, leptin, weight
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要